Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity.

Gragnoli C, Reeves GM, Reazer J, Postolache TT. Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity. Transl Psychiatry. 2016 Apr 19; 6:e785.

View in: PubMed